Tag: Alnylam Pharmaceuticals

Clinical Trials, Mergers and Acquisitions, Research and Development

Alnylam, Vir team up to develop siRNAs to tackle COVID-19

March 4, 2020

Via: FierceBiotech

Alnylam Pharmaceuticals and Vir Biotechnology have teamed up to develop RNAi therapeutics against the coronavirus behind the COVID-19 outbreak. The collaboration builds on Alnylam synthesis of siRNAs that target highly conserved regions of coronavirus RNA. Vir and Alnylam joined forces […]